Analysis of the Type 2 Diabetes-Associated Single Nucleotide Polymorphisms in the Genes IRS1, KCNJ11, and PPARG2 in Type 1 Diabetes

Diabetes

Volumn 53, Issue 3, 2004, Pages 870-873

  Eftychi, Christina ^a   Howson, Joanna M M ^a   Barratt, Bryan J ^a   Vella, Adrian ^a   Payne, Felicity ^a   Smyth, Deborah J ^a   Twells, Rebecca C J ^a   Walker, Neil M ^a   Rance, Helen E ^a   Tuomilehto Wolf, Eva ^b   Tuomilehto, Jaakko ^b   Undlien, Dag E ^c   Rønningen, Kjersti S ^d   Guja, Cristian ^e   Ionescu Tîrgovişte, Constantin ^e   Savage, David A ^f   Todd, John A ^a,g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e Institute of Diabetes   (Romania)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GLYCINE; INSULIN RECEPTOR SUBSTRATE 1; INWARDLY RECTIFYING POTASSIUM CHANNEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; UNCLASSIFIED DRUG;

ARTICLE; EUROPE; FAMILIAL DISEASE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; CANADA; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; MALE; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 10744223678     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.3.870     Document Type: Article

References (30)

1. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T: Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455-470, 2003
2. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
3. Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44:914-922, 2001
4. Greenbaum CJ, Prigeon RL, D'Alessio DA: Impaired β-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes 51:951-957, 2002
5. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S: The Swedish childhood diabetes study: results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32:2-6, 1989
6. Li H, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T: Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 86:574-582, 2001
7. Tuomilehto-Wolf E, Tuomilehto J, Hitman GA, Nissinen A, Stengard J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen MJ: Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 307:155-159, 1993
8. Bennett ST, Todd JA: Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 30:343-370, 1996
9. Florez JC, Hirschhorn J, Altshuler D: The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Ann Rev Genomics Hum Genet 4:257-291, 2003
10. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM: Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568-572, 2003
11. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste C, Stevens H, Carr P, Nutland S, McKinney P, Shield JP, Wang W, Cordell HJ, Walker N, Todd JA, Concannon P: Parameters for reliable results in genetic association studies in common disease. Nat Genet 30:149-150, 2002
12. 972→ Arg IRS-1 variant is associated with type 1 diabetes in continental Italy. Diabetes 52:887-890, 2003
13. Lee CH, Olson P, Evans RM: Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207, 2003
14. Spiegelman BM: PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
15. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPAR-gamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
16. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC: Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). Diabet Med 18:206-212, 2001
17. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 41:1511-1515, 1998
18. + channels. Diabetes 51:875-879, 2002
19. Palmer JP: Beta cell rest and recovery: does it bring patients with latent autoimmune diabetes in adults to euglycemia? Ann N Y Acad Sci 958:89-98, 2002
20. Burks DJ, White MF: IRS proteins and β-cell function. Diabetes 50 (Suppl. 1):S140-S145, 2001
21. Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP: Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 46:990-995, 2003
22. Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P: Troglitazone prevents insulin dependent diabetes in the nonobese diabetic mouse. Eur J Pharmacol 357:221-225, 1998
23. Beales PE, Pozzilli P: Thiazohdinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabete Metab Res Rev 18:114-117, 2002
24. Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E: Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Biochem Biophys Res Commun 304:378-384, 2003
25. Nezhentsev S, Guja C, McCormack R, Cooper J, Howson JMM, Nutland S, Rance H, Walker N, Undlien D, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Ionescu-Tirgoviste C, Gale EAM, Bingley PJ, Gillespie KM, Savage DA, Carson DJ, Patterson CC, Maxwell AP, Todd JA: The ARG241 allele of the intercellular adhesion molecule-1 is associated with a reduced risk of type 1 diabetes. Lancet 362:1723-1724, 2003
26. Bain SC, Todd JA, Barnett AH: The British Diabetic Association: Warren repository. Autoimmunity 7:83-85, 1990
27. Lernmark A, Ducat L, Eisenbarth G, Ott J, Permutt MA, Rubenstein P, Spielman R: Family cell lines available for research. Am J Hum Genet 47:1028-1030, 1990
28. Patterson CC, Carson DJ, Hadden DR, the Northern Ireland Diabetes Study Group: Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most house-hold crowding. Diabetologia 39:1063-1069, 1996
29. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Akerblom HK, the Childhood Diabetes in Finland (DiMe) Study Group: Epidemiology of childhood diabetes mellitus in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70-76, 1992
30. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70:124-141, 2002